These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37337170)

  • 1. A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer.
    Zhang Y; Dong K; Jia X; Du S; Wang D; Wang L; Qu H; Zhu S; Wang Y; Wang Z; Zhang S; Sun W; Fu S
    BMC Med Genomics; 2023 Jun; 16(1):140. PubMed ID: 37337170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
    Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
    J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response.
    Lian X; Liu B; Wang C; Wang S; Zhuang Y; Li X
    Front Endocrinol (Lausanne); 2023; 14():1182776. PubMed ID: 37342266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer.
    Zhou C; Ma J; Luo W; Hu J; Chen J; Liang S; He S
    Biochem Genet; 2024 Feb; 62(1):112-124. PubMed ID: 37270714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA.
    Yang S; Ji J; Wang M; Nie J; Wang S
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9.
    Luo X; Wang Y; Zhang H; Chen G; Sheng J; Tian X; Xue R; Wang Y
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome sequencing of extrachromosomal circular DNA of cerebrospinal fluid of medulloblastoma.
    Zhu Y; Liu Z; Guo Y; Li S; Qu Y; Dai L; Chen Y; Ning W; Zhang H; Ma L
    Front Oncol; 2022; 12():934159. PubMed ID: 36452490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
    Fei H; Han X; Wang Y; Li S
    J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a glycolysis-related gene signature for survival prediction of ovarian cancer patients.
    Zhang D; Li Y; Yang S; Wang M; Yao J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Dai Z; Kang H
    Cancer Med; 2021 Nov; 10(22):8222-8237. PubMed ID: 34609082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients.
    Zhu Z; Geng R; Zhang Y; Liu J; Bai J
    J Immunol Res; 2023; 2023():8727884. PubMed ID: 36726489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel gene signatures for prognosis prediction in ovarian cancer.
    Bao M; Zhang L; Hu Y
    J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Wang Y
    J Ovarian Res; 2023 Apr; 16(1):86. PubMed ID: 37120633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Xu Y; Wang Y
    J Ovarian Res; 2023 Sep; 16(1):196. PubMed ID: 37730669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic characterization of alternative splicing related to prognosis, immune infiltration, and drug sensitivity analysis in ovarian cancer.
    Liu Q; Zhang H; Yang X; Liu X; Yin F; Guo P; Yin Y; Zheng K; Yang Z; Han Y
    Ann Transl Med; 2022 Jan; 10(2):126. PubMed ID: 35282039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance and immune infiltration analyses of a novel coagulation-related signature in ovarian cancer.
    Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Sheng J; Voon DC; Wang Y
    Cancer Cell Int; 2023 Oct; 23(1):232. PubMed ID: 37803446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognosis-predictive nomogram of ovarian cancer with two immune-related genes:
    Lin H; Wang J; Wen X; Wen Q; Huang S; Mai Z; Lu L; Liang X; Pan H; Li S; He Y; Ma H
    Oncol Lett; 2020 Nov; 20(5):204. PubMed ID: 32963610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal Muscles of Sedentary and Physically Active Aged People Have Distinctive Genic Extrachromosomal Circular DNA Profiles.
    Gerovska D; Araúzo-Bravo MJ
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer.
    Wei X; Hu W; Mao K
    Medicine (Baltimore); 2023 Feb; 102(5):e32766. PubMed ID: 36749233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
    Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J
    Front Genet; 2022; 13():1001239. PubMed ID: 36425071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.